Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Where stroke treatment came from

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

For almost all of medical history, a stroke was something you watched. The word apoplexy meant struck down, and the treatment was nursing and hope.

Two moments changed that: a trial reported in 1995, and five trials reported within months of each other in 2015.

Related pages: Stroke

The bottom line

What we know
  • Apoplexy was described in antiquity and attributed to humoral imbalance.
  • The vascular cause was established over the 17th to 19th centuries.
  • Organised stroke unit care was shown to improve survival before any drug existed.
  • The NINDS trial in 1995 showed thrombolysis improved outcomes.
  • Thrombectomy trials reported in 2015 transformed treatment of large vessel strokes.
What is still open
  • Why thrombolysis took so long to be widely adopted.
  • Why earlier thrombectomy trials failed before 2015.

The story, step by step

  1. 1. Apoplexy ()
  2. 2. The quiet advance ()
  3. 3. 1995 ()
  4. 4. 2015 ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

Struck down

Small or early study

What happens

Observed for millennia, explained by none of it.

What the research shows

  • Hippocratic writings describe sudden paralysis and loss of speech, using the term apoplexy, meaning struck down violently.
  • The cause was attributed to an imbalance of humours, and treatment was bloodletting, purging and rest, which made things worse.
  • In the 17th century Thomas Willis mapped the arterial ring at the base of the brain that still carries his name, and recognised that blocked blood supply could cause the syndrome.
  • Johann Jakob Wepfer, in 1658, showed through autopsies that apoplexy could be caused by bleeding into the brain and by blocked arteries.
  • Rudolf Virchow in the 19th century described thrombosis and embolism, establishing that clots could form in one place and lodge in another.
  • By 1900 the mechanism was broadly understood and there was still nothing to do about it.

Why it matters

Understanding came centuries before treatment, which is a recurring pattern and an uncomfortable one for the patients in between.

What's still uncertain

  • How much earlier the vascular cause was suspected.

Read more

Next: The quiet advance

Part 2 of 4

Stroke units

Small or early study

What happens

Organisation, before drugs.

What the research shows

  • Through the 20th century, treatment remained supportive: bed rest, nursing and, eventually, rehabilitation.
  • Rehabilitation itself developed substantially after the two world wars, driven by the need to rehabilitate injured soldiers.
  • From the 1960s, trials began comparing care on a dedicated stroke unit with care on a general ward.
  • Stroke units reduced death and dependency substantially, with no new drug involved: coordinated specialist nursing, early mobilisation, swallowing assessment, and prevention of complications.
  • This remains one of the best-evidenced interventions in stroke care, and it benefits every patient rather than the minority eligible for acute treatment.
  • The finding that organisation alone saved lives was initially met with limited enthusiasm, because it was not a discovery that could be packaged.

Why it matters

Across a population, stroke units save more lives than clot-dissolving drugs do, and they attract a fraction of the attention.

What's still uncertain

  • Why stroke unit implementation remains incomplete.

Read more

Next: 1995

Part 3 of 4

The NINDS trial

Small or early study

What happens

The first treatment that reversed a stroke.

What the research shows

  • Clot-dissolving drugs were already used in heart attacks. Applying them to stroke was feared, because of bleeding into damaged brain.
  • Earlier European trials using longer time windows had shown harm, which made the field cautious.
  • The NINDS trial, reported in 1995, gave alteplase within three hours of symptom onset and found significantly more patients with little or no disability at three months.
  • It also found more bleeding into the brain, which is the trade-off that still shapes practice.
  • The key insight was the time window. The same drug given later caused harm; given early it helped.
  • Adoption was slow and contested for years, partly because hospitals could not reliably deliver the drug fast enough, which prompted the restructuring of emergency stroke care.

Why it matters

The drug did not change outcomes on its own. The systems built to deliver it in time did, and that took another decade.

What's still uncertain

  • Why adoption took so long after publication.

Read more

Next: 2015

Part 4 of 4

Thrombectomy

Small or early study

What happens

Five trials in one year.

What the research shows

  • Mechanical clot retrieval had been attempted for years, and trials published in 2013 were negative, which nearly closed the field.
  • Those trials had used older devices and had not reliably selected patients with large vessel blockages.
  • Between late 2014 and 2015, five randomised trials using modern stent-retrievers and better patient selection all reported substantial benefit, several stopped early for efficacy.
  • The effect size was unusually large: in some trials, treating a handful of patients produced one additional person living independently.
  • Later trials extended the window to 16 and then 24 hours in patients selected by imaging rather than by the clock alone.
  • The remaining problem became logistical: thrombectomy requires a specialist team and suite, which reorganised how ambulances route stroke patients.

Why it matters

The 2013 failures and the 2015 successes used the same idea with better tools and better selection, which is a useful caution about declaring an approach dead.

What's still uncertain

  • How to extend thrombectomy access geographically.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.